about
Smoking modifies the relationship between XRCC1 haplotypes and HPV16-negative head and neck squamous cell carcinomaProphylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursorsRisk for cervical intraepithelial neoplasia grade 3 or worse in relation to smoking among women with persistent human papillomavirus infectionHuman Papillomavirus Infection as a Possible Cause of Spontaneous Abortion and Spontaneous Preterm DeliveryEpidemiology of ocular surface squamous neoplasia in AfricaCutaneous squamous cell carcinoma and human papillomavirus: is there an association?Distribution patterns of infection with multiple types of human papillomaviruses and their association with risk factorsType-specific HPV prevalence in cervical cancer and high-grade lesions in Latin America and the Caribbean: systematic review and meta-analysisHuman papillomavirus and head and neck carcinomas: focus on evidence in the babel of published dataSeroprevalence of 34 human papillomavirus types in the German general population.Human papillomavirus type 16 viral load measurement as a predictor of infection clearance.Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistenceDiagnosis of 25 genotypes of human papillomaviruses for their physical statuses in cervical precancerous/cancerous lesions: a comparison of E2/E6E7 ratio-based vs. multiple E1-L1/E6E7 ratio-based detection techniquesResults of the first World Health Organization international collaborative study of detection of human papillomavirus DNA.Isolation of three novel rat and mouse papillomaviruses and their genomic characterizationHuman papillomavirus detection from human immunodeficiency virus-infected Colombian women's paired urine and cervical samplesNo role for human papillomavirus in esophageal squamous cell carcinoma in China.Human papillomavirus testing with the hybrid capture 2 assay and PCR as screening tools.A population-based observational study comparing Cervista and Hybrid Capture 2 methods: improved relative specificity of the Cervista assay by increasing its cut-off.Detection of HPV DNA and immunohistochemical expression of cell cycle proteins in oral carcinoma in a population of Brazilian patients.Evaluation of using composite HPV genotyping assay results to monitor human papillomavirus infection burden through simulationOncogenic HPV Types Infection in Adolescents and University Women from North Portugal: From Self-Sampling to Cancer Prevention.Comparison of the SPF10-LiPA system to the Hybrid Capture 2 Assay for detection of carcinogenic human papillomavirus genotypes among 5,683 young women in Guanacaste, Costa RicaHead-to-Head Comparison of the RNA-Based Aptima Human Papillomavirus (HPV) Assay and the DNA-Based Hybrid Capture 2 HPV Test in a Routine Screening Population of Women Aged 30 to 60 Years in Germany.Rate of vertical transmission of human papillomavirus from mothers to infants: relationship between infection rate and mode of deliveryComparison of DNA testing strategies in monitoring human papillomavirus infection prevalence through simulation.Study-based evaluation of the Abbott RealTime High Risk HPV test in comparison to the HC2 HR HPV test in women aged ≥30 years using residual LBC ThinPrep specimens.Predictors of human papillomavirus infection in women undergoing routine cervical cancer screening in Spain: the CLEOPATRE study.Parity as a cofactor for high-grade cervical disease among women with persistent human papillomavirus infection: a 13-year follow-upDetection and typing of human papilloma virus by multiplex PCR with type-specific primers.Application of multiplex PCR for Rapid and sensitive detection of human papillomaviruses in cervical cancerGuidelines of the Italian Society for Virology on HPV testing and vaccination for cervical cancer prevention.Comparison of Two Widely Used Human Papillomavirus Detection and Genotyping Methods, GP5+/6+-Based PCR Followed by Reverse Line Blot Hybridization and Multiplex Type-Specific E7-Based PCR.Validation of the SPF10 LiPA human papillomavirus typing assay using formalin-fixed paraffin-embedded cervical biopsy samples.Posttreatment human papillomavirus testing for recurrent cervical intraepithelial neoplasia: a systematic reviewAcquisition of high-risk human papillomavirus infection in a population-based cohort of Danish women.Clinical Evaluation of INNO-LiPA HPV Genotyping II Assay Using the VALGENT Framework
P2860
Q23916001-BC1AD0D9-7D13-4D50-9778-E8B6A14D3BBBQ24235373-A95C8F81-39A1-4D40-8D48-6262311AABB2Q24568227-FDEE5FA7-4819-4293-AC6E-A7BBB864F7C5Q26750738-F9A73C11-34F2-47EC-9D5E-DD6BB9131437Q26860642-B16442BA-89A5-4457-B41F-A1704B10EE87Q27693832-B98C42C7-FCA4-488B-98C3-C9418040F33EQ28742649-7D4BCE8A-87D2-4B74-AA6D-7FBD783D793BQ28744257-5B7E21BE-8F04-4395-B37D-E7477646DDDEQ31136389-518F65BD-2934-4F45-A82D-903599014187Q33345224-E23F7669-904B-4ED5-A7E0-83B4362525E1Q33887322-FBDE66DB-4A5E-4183-B241-2113A31230C6Q34176414-78693477-BE74-48C6-B55D-1F85EE4012F2Q34317107-6321D98A-7B01-488F-AF22-6DEFF88A1011Q34430779-B2A077C4-2EA7-47B8-9C22-EB6513975C4AQ34450609-CEA0F478-1B4B-4224-B4EE-EB79CCA63F31Q34590155-DAA1BE18-BEF8-47A6-9D21-A65E518B8DF4Q34756499-3F66B9C1-C51C-440A-A2CC-F13AA1F048FEQ34783310-401A8855-A44A-431A-A52C-F9DCB2BB60FBQ34789131-1098E2E7-E60A-49AC-AEBE-BD624D336E03Q35082076-5A185F7E-8DC5-4825-AE21-399790AD4BB4Q35185477-C42E2CEE-6933-4B21-A4BC-C8A0B7670CBDQ35585448-9B75EE3B-53E9-40B2-9E70-ED87E1B59FB9Q35784544-854F29B9-D3A5-4B89-A04E-7C3C86D75548Q35868702-43D06582-3FAF-4417-9F54-E2BB18D210F4Q36167845-18372FF0-E7A7-42C7-AA4E-7B598A101772Q36184620-0A28F0D4-5AFE-4CDC-9BEF-BF85E72D9B6AQ36190228-44200127-93EF-4C82-97EB-5FF23643CD52Q36249128-01DFC0BB-50F7-45D5-8340-E2DBBF414F3AQ36557818-20CBCA55-6B36-4481-B4A5-AE83A04C7AA0Q36857709-C24E1B9F-3B93-453E-A0A1-C73B788EBB21Q36876471-7478A29D-06CA-47AD-AA35-EA9CB20A8E01Q37066141-3B738F5A-81B6-435B-8055-09D915E6B055Q37132091-61968E99-B121-49ED-9C84-08209C96616FQ37256252-E179F8B1-81DE-41FF-BC03-10C2DD0F1D24Q37376872-F1A7D964-FA5B-4433-9F3B-3D751880CA25Q37461655-5BC425A3-B380-4CFA-B884-DBF635F02416Q58749448-23CFCA5D-08DF-4276-A985-AC23581DA733
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Chapter 12: Human papillomavirus technologies.
@ast
Chapter 12: Human papillomavirus technologies.
@en
type
label
Chapter 12: Human papillomavirus technologies.
@ast
Chapter 12: Human papillomavirus technologies.
@en
prefLabel
Chapter 12: Human papillomavirus technologies.
@ast
Chapter 12: Human papillomavirus technologies.
@en
P1476
Chapter 12: Human papillomavirus technologies
@en
P2093
Luisa Lina Villa
Thomas Iftner
P356
10.1093/OXFORDJOURNALS.JNCIMONOGRAPHS.A003487
P577
2003-01-01T00:00:00Z